— Fundamental Stock Analysis and Report Card
Located in Woonsocket, RI, US. CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Revenue, earnings and profitability.
Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.
Revenue History
Earnings History
Margins
Income & Cash Flow analysis.
An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.
Q1 2026 Total ($) | Q1 2026 Margin (%) | |
|---|---|---|
| Revenue | 100.4b +5.8b +6.2% | |
| Gross Income | 15.6b +1.2b +8.5% | 16% +0.3pp +2.2% |
| EBITDA | 5.8b +1.3b +27.9% | 6% +1.0pp +20.5% |
| Operating Income | 4.7b +1.3b +38.7% | 5% +1.1pp +30.6% |
| Net Income | 2.9b +1.2b +65.4% | 3% +1.0pp +55.8% |
| Earnings Per Share | 2.31 +0.9 +63.8% | |
| Operating Cash Flow | 4.2b -307.0m -6.7% | 4% -0.6pp -12.2% |
| Free Cash Flow | 3.4b -413.0m -10.8% | 3% -0.6pp -16.0% |
| Research & Development | n/a n/a n/a | n/a n/a n/a |
What are the analysts saying?
Analyst Consensus aggregates Wall Street recommendations into buy/hold/sell counts, while the Fundamental Scorecard grades the company on six financial ratios (P/B, P/E, D/E, ROA, ROE, DCF) plus an overall score. The two measure different things and can point in different directions.